Home » AstraZeneca vaccine, agreement with the EU: legal battle ends

AstraZeneca vaccine, agreement with the EU: legal battle ends

by admin

The terms of the agreement

deepening


Coronavirus in Italy and in the world: the news of September 3. LIVE

Specifically, the agreement, as explained by the EU Commission, “provides for AstraZeneca’s firm commitment to deliver, in addition to the approximately 100 million doses delivered up to the end of the second quarter, 135 million doses by the end of 2021”. The delivery schedule will be outlined as follows: 60 million doses by the end of the third quarter, 75 million by the end of the fourth, and the remaining 65 million by the end of March 2022. “This will bring the total number of doses administered to 300. millions of doses as contractually agreed “, explains Brussels in the note. Delivery schedules will be provided to Member States and discounts will apply in the event of delays. “Today’s agreement guarantees the delivery of the remaining 200 million doses of Covid-19 vaccine by AstraZeneca to the EU,” said EU Commissioner for Health and Food Safety, Stella Kyriakides, commenting on the agreement. “Although this week we reached the important milestone of full vaccination for 70% of adults in the EU, there are significant differences in vaccination rates between our Member States and the continued availability of vaccines, including that of AstraZeneca, remains. crucial – he added -. And as the strongest supporter of cooperation and global solidarity on vaccines, we will continue to help the rest of the world. The goal is to share at least 200 million doses of vaccines through Covax with low- and middle-income countries. until the end of this year “. “Vaccine solidarity is and remains our trademark,” concluded Kyriakides.

See also  Covid variants, in the race to fight them Italy is behind

.

You may also like

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy